TestAVec at BSGCT annual conference

TestaVec was proud to sponsor the annual conference of the British Society for Gene and Cell Therapy, held this year in Newcastle. Representing the company were CSO Mike Themis, Associate Scientist Hassan Abdulrazzak, and Principal Scientific Officer Saqlain Suleman.

The conference proved to be highly engaging, offering valuable opportunities for discussion with a wide range of scientists from both academia and industry. These conversations highlighted the continued momentum and innovation within the gene and cell therapy field.

As part of the scientific programme, Saqlain delivered a presentation on hInGeTox, our flagship model for assessing vector safety. The talk generated strong interest and sparked insightful discussions around advancing safer and more effective gene therapy approaches.